Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer - PubMed (original) (raw)
Affiliations
- PMID: 9360417
Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer
A Cardone et al. Panminerva Med. 1997 Sep.
Abstract
Objective: To ascertain whether the prognostic value of desmoplastic reaction and lymphocytic infiltration are a good prognostic index to estimate survival in breast cancer patients.
Methods: From 1987 to 1994, the authors have evaluated the prognostic value of desmoplastic reaction and lymphocytic infiltration related to rode state in 34 patients with breast cancer. For statistical analysis and comparison of means the "t"-test was used. The significance level was 0.01.
Results: The group of patients with abundant desmoplastic reaction shows an overall survival rate lower than the group with poor desmoplastic reaction (p < 0.01) and the survival of the group with abundant desmoplastic reaction was related to lymphnodal status.
Conclusions: Many prognostic factors have been shown during these years, some connected to patient, some connected to neoplasm and others connected to the treatment. Recently many other prognostic factors have been recognized, among which the possible prognostic role of desmoplasia has been carefully valued. Certainly, today the prognostic value of desmoplastic reaction and lymphocytic infiltration cannot take the place of usual prognostic factors in the evaluation of breast cancer patient yet the desmoplastic reaction is a good prognostic index to estimate the survival in these patients.
Similar articles
- [Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study].
Mezi S, Aloise G, Marzullo A, Marchei P, Di Benedetto A, Modica A, Vasaturo F, Modesti M. Mezi S, et al. G Chir. 1997 May;18(5):263-8. G Chir. 1997. PMID: 9312252 Italian. - Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A, Talieri M, Ardavanis A, Courtis N, Dimitriadis E, Yotis J, Tsiapalis CM, Trangas T. Scorilas A, et al. Cancer Res. 2000 Oct 1;60(19):5427-33. Cancer Res. 2000. PMID: 11034084 - Lymphocytic infiltration surrounding liver metastases from colorectal cancer.
Okano K, Maeba T, Moroguchi A, Ishimura K, Karasawa Y, Izuishi K, Goda F, Usuki H, Wakabayashi H, Maeta H. Okano K, et al. J Surg Oncol. 2003 Jan;82(1):28-33. doi: 10.1002/jso.10188. J Surg Oncol. 2003. PMID: 12501166 - 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M. Di Saverio S, et al. Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review. - [Classical prognostic factors in breast cancer].
Böhm J, Höfler H. Böhm J, et al. Rontgenpraxis. 1993 Dec;46(12):378-81. Rontgenpraxis. 1993. PMID: 8303470 Review. German. No abstract available.
Cited by
- A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers.
Sulaiman R, Koirala N, Aske JC, Lin X, Rojas-Espaillat L, Starks D, Dale A, Gaster K, De P, Dey N. Sulaiman R, et al. Am J Cancer Res. 2024 Feb 15;14(2):467-489. doi: 10.62347/NJRZ3602. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455423 Free PMC article. - Schirrous invasive ductal carcinoma of the breast overexpress p53 oncoprotein.
Ferrini FS, Rossi MA, Neto MM, Soares FA. Ferrini FS, et al. Sao Paulo Med J. 2001 Jan 4;119(1):4-6. doi: 10.1590/s1516-31802001000100002. Sao Paulo Med J. 2001. PMID: 11175617 Free PMC article. - Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.
Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D. Mishra PJ, et al. Cancer Res. 2008 Jun 1;68(11):4331-9. doi: 10.1158/0008-5472.CAN-08-0943. Cancer Res. 2008. PMID: 18519693 Free PMC article. - Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness.
Avgustinova A, Iravani M, Robertson D, Fearns A, Gao Q, Klingbeil P, Hanby AM, Speirs V, Sahai E, Calvo F, Isacke CM. Avgustinova A, et al. Nat Commun. 2016 Jan 18;7:10305. doi: 10.1038/ncomms10305. Nat Commun. 2016. PMID: 26777421 Free PMC article. - Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility.
Aprelikova O, Palla J, Hibler B, Yu X, Greer YE, Yi M, Stephens R, Maxwell GL, Jazaeri A, Risinger JI, Rubin JS, Niederhuber J. Aprelikova O, et al. Oncogene. 2013 Jul 4;32(27):3246-53. doi: 10.1038/onc.2012.351. Epub 2012 Aug 13. Oncogene. 2013. PMID: 22890324 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical